Ventricular fibrillation: triggers, mechanisms and therapies.
暂无分享,去创建一个
Gordon Ho | C. Villongco | D. Krummen | Justin Hayase | David E Krummen | Justin Hayase | Christopher T Villongco | Amir A Schricker | A. Schricker | Gordon Ho
[1] J. Olgin,et al. Effects of Thoracic Spinal Cord Stimulation on Cardiac Autonomic Regulation of the Sinus and Atrioventricular Nodes , 2002, Journal of cardiovascular electrophysiology.
[2] S. Narayan,et al. A case of a human ventricular fibrillation rotor localized to ablation sites for scar-mediated monomorphic ventricular tachycardia. , 2013, Heart rhythm.
[3] R. von Känel,et al. Chronic posttraumatic stress and its predictors in patients living with an implantable cardioverter defibrillator. , 2011, Journal of affective disorders.
[4] O. Berenfeld,et al. Molecular mechanisms and global dynamics of fibrillation: an integrative approach to the underlying basis of vortex-like reentry. , 2004, Journal of theoretical biology.
[5] Karl Swedberg,et al. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. , 2003, The New England journal of medicine.
[6] D. Zipes,et al. Thoracic Spinal Cord Stimulation Reduces the Risk of Ischemic Ventricular Arrhythmias in a Postinfarction Heart Failure Canine Model , 2005, Circulation.
[7] Jichao Zhao,et al. Atrial fibrillation driven by micro-anatomic intramural re-entry revealed by simultaneous sub-epicardial and sub-endocardial optical mapping in explanted human hearts. , 2015, European heart journal.
[8] J Jalife,et al. Purkinje-muscle reentry as a mechanism of polymorphic ventricular arrhythmias in a 3-dimensional model of the ventricles. , 1998, Circulation research.
[9] R. Kloner,et al. Improved Left Ventricular Function and Reduced Necrosis after Myocardial Ischemia/Reperfusion in Rabbits Treated with Ranolazine, an Inhibitor of the Late Sodium Channel , 2006, Journal of Pharmacology and Experimental Therapeutics.
[10] N. Freemantle,et al. Cardiovascular outcomes in the AFFIRM Trial (Atrial Fibrillation Follow-Up Investigation of Rhythm Management). An assessment of individual antiarrhythmic drug therapies compared with rate control with propensity score-matched analyses. , 2011, Journal of the American College of Cardiology.
[11] Kumaraswamy Nanthakumar,et al. Intramural Activation During Early Human Ventricular Fibrillation , 2011, Circulation. Arrhythmia and electrophysiology.
[12] Frank Bogun,et al. Relationship between burden of premature ventricular complexes and left ventricular function. , 2010, Heart rhythm.
[13] S. Narayan,et al. Percutaneous Stellate Ganglion Block Suppressing VT and VF in a Patient Refractory to VT Ablation , 2013, Journal of cardiovascular electrophysiology.
[14] J F Leclercq,et al. Ambulatory sudden cardiac death: mechanisms of production of fatal arrhythmia on the basis of data from 157 cases. , 1989, American heart journal.
[15] M. Vargas,et al. Effects of in-hospital low targeted temperature after out of hospital cardiac arrest: A systematic review with meta-analysis of randomized clinical trials. , 2015, Resuscitation.
[16] Richard H Clayton,et al. Human Ventricular Fibrillation During Global Ischemia and Reperfusion: Paradoxical Changes in Activation Rate and Wavefront Complexity , 2011, Circulation. Arrhythmia and electrophysiology.
[17] Mehra,et al. A prospective, randomized, double-blind, crossover study to compare the efficacy and safety of chronic nifedipine therapy with that of isosorbide dinitrate and their combination in the treatment of chronic congestive heart failure. , 1990, Circulation.
[18] José Jalife,et al. Rotors and the Dynamics of Cardiac Fibrillation , 2013, Circulation research.
[19] M. Kayıkçıoğlu,et al. Tachycardia‐Induced Cardiomyopathy in Patients With Idiopathic Ventricular Arrhythmias: The Incidence, Clinical and Electrophysiologic Characteristics, and the Predictors , 2011, Journal of cardiovascular electrophysiology.
[20] O. Berenfeld,et al. Shaping of a scroll wave filament by cardiac fibers. , 2001, Physical review. E, Statistical, nonlinear, and soft matter physics.
[21] Tae Yun Kim,et al. Spatially Discordant Alternans and Arrhythmias in Tachypacing-Induced Cardiac Myopathy in Transgenic LQT1 Rabbits: The Importance of IKs and Ca2+ Cycling , 2015, PloS one.
[22] Michel Haïssaguerre,et al. Mapping and Ablation of Idiopathic Ventricular Fibrillation , 2002, Frontiers in cardiovascular medicine.
[23] Thomas Lavergne,et al. Sudden cardiac arrest associated with early repolarization. , 2008, The New England journal of medicine.
[24] R. A. Gray,et al. Mechanisms of Cardiac Fibrillation , 1995, Science.
[25] D. Rosenbaum,et al. Connexin Gene Transfer Preserves Conduction Velocity and Prevents Atrial Fibrillation , 2012, Circulation.
[26] J. Nolasco,et al. A graphic method for the study of alternation in cardiac action potentials. , 1968, Journal of applied physiology.
[27] J. K. Donahue,et al. Gene therapy approaches to ventricular tachyarrhythmias. , 2007, Journal of electrocardiology.
[28] J. Oss,et al. PROPHYLACTIC IMPLANTATION OF A DEFIBRILLATOR IN PATIENTS WITH MYOCARDIAL INFARCTION AND REDUCED EJECTION FRACTION , 2002 .
[29] O. Berenfeld,et al. Dynamics of intramural scroll waves in three-dimensional continuous myocardium with rotational anisotropy. , 1999, Journal of theoretical biology.
[30] Yi Zheng,et al. Ventricular fibrillation mechanisms and cardiac restitutions: An investigation by simulation study on whole-heart model , 2015, Comput. Biol. Medicine.
[31] W. Rheinboldt,et al. A COMPUTER MODEL OF ATRIAL FIBRILLATION. , 1964, American heart journal.
[32] Juan Cinca,et al. Soluble ST2 for predicting sudden cardiac death in patients with chronic heart failure and left ventricular systolic dysfunction. , 2009, Journal of the American College of Cardiology.
[33] C. Callaway,et al. Regional variation in out-of-hospital cardiac arrest incidence and outcome. , 2008, JAMA.
[34] S. Priori,et al. Left Cardiac Sympathetic Denervation in the Management of High-Risk Patients Affected by the Long-QT Syndrome , 2004, Circulation.
[35] J. Mcanulty,et al. Use of implantable cardioverter-defibrillators in the congenital long QT syndrome. , 1996, The American journal of cardiology.
[36] Bruce B. Lerman,et al. Reversal of Cardiomyopathy in Patients With Repetitive Monomorphic Ventricular Ectopy Originating From the Right Ventricular Outflow Tract , 2005, Circulation.
[37] M. Franz. The Electrical Restitution Curve Revisited: , 2003, Journal of cardiovascular electrophysiology.
[38] G. Breithardt,et al. Efficacy of Antiarrhythmic Drugs in Patients With Arrhythmogenic Right Ventricular Disease: Results in Patients With Inducible and Noninducible Ventricular Tachycardia , 1992, Circulation.
[39] R. Prescott,et al. CONTROLLED TRIAL OF SOTALOL FOR ONE YEAR AFTER MYOCARDIAL INFARCTION , 1982, The Lancet.
[40] R. Hauer,et al. Not all beta-blockers are equal in the management of long QT syndrome types 1 and 2: higher recurrence of events under metoprolol. , 2012, Journal of the American College of Cardiology.
[41] M. Pfeffer,et al. Effect of angiotensin converting enzyme inhibition on sudden cardiac death in patients following acute myocardial infarction. A meta-analysis of randomized clinical trials. , 1999, Journal of the American College of Cardiology.
[42] Robert G. Weiss,et al. Magnetic Resonance Assessment of the Substrate for Inducible Ventricular Tachycardia in Nonischemic Cardiomyopathy , 2005, Circulation.
[43] R. Gray,et al. Spatial and temporal organization during cardiac fibrillation , 1998, Nature.
[44] Kenneth Egstrup,et al. Effect of dofetilide in patients with recent myocardial infarction and left-ventricular dysfunction: a randomised trial , 2000, The Lancet.
[45] S. Steen,et al. Continuous intratracheal insufflation of oxygen improves the efficacy of mechanical chest compression-active decompression CPR. , 2004, Resuscitation.
[46] B. Desjardins,et al. Impact of radiofrequency ablation of frequent post-infarction premature ventricular complexes on left ventricular ejection fraction. , 2009, Heart rhythm.
[47] H. Calkins,et al. Clinical course and long-term follow-up of patients receiving implantable cardioverter-defibrillators. , 2006, Heart rhythm.
[48] M. Link,et al. 2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2012, Journal of the American College of Cardiology.
[49] K. Anstrom,et al. Mortality benefits from implantable cardioverter-defibrillator therapy are not restricted to patients with remote myocardial infarction: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). , 2011, Heart rhythm.
[50] A. Toso,et al. Results of nonguided subtotal endocardiectomy associated with left ventricular reconstruction in patients with ischemic ventricular arrhythmias. , 1994, The Journal of thoracic and cardiovascular surgery.
[51] E. McVeigh,et al. Model of reentrant ventricular tachycardia based on infarct border zone geometry predicts reentrant circuit features as determined by activation mapping. , 2007, Heart rhythm.
[52] Peng-Sheng Chen,et al. Effects of Subendocardial Ablation on Anodal Supernormal Excitation and Ventricular Vulnerability in Open‐Chest Dogs , 1993, Circulation.
[53] S. Russell,et al. Outcomes of Catheter Ablation of Ventricular Tachycardia in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy , 2012, Circulation. Arrhythmia and electrophysiology.
[54] R. W. Joyner,et al. Cellular mechanisms of delayed recovery of excitability in ventricular tissue. , 1991, The American journal of physiology.
[55] Javier Moreno,et al. Three distinct phases of VF during global ischemia in the isolated blood-perfused pig heart. , 2007, American journal of physiology. Heart and circulatory physiology.
[56] B Lown,et al. Predictors of antiarrhythmic drug efficacy in patients with malignant ventricular tachyarrhythmias. , 1987, American heart journal.
[57] Wouter-Jan Rappel,et al. Rotor stability separates sustained ventricular fibrillation from self-terminating episodes in humans. , 2014, Journal of the American College of Cardiology.
[58] GISSI-Prevenzione Investigators,et al. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial , 1999, The Lancet.
[59] F. Marchlinski,et al. Symptoms and electrocardiographically documented rhythm preceding spontaneous shocks in patients with implantable cardioverter-defibrillator. , 1993, The American journal of cardiology.
[60] Elliot B. Bourgeois,et al. Panoramic optical mapping shows wavebreak at a consistent anatomical site at the onset of ventricular fibrillation. , 2012, Cardiovascular research.
[61] S. S. Hull,et al. Vagal stimulation and prevention of sudden death in conscious dogs with a healed myocardial infarction. , 1991, Circulation research.
[62] G. Gintant,et al. Heterogeneity within the ventricular wall. Electrophysiology and pharmacology of epicardial, endocardial, and M cells. , 1991, Circulation research.
[63] G. Kay,et al. Idiopathic Focal Ventricular Arrhythmias Originating from the Anterior Papillary Muscle in the Left Ventricle , 2009, Journal of cardiovascular electrophysiology.
[64] S. Viskin,et al. Effects of Electrophysiologic‐Guided Therapy with Class IA Antiarrhythmic Drugs on the Long‐Term Outcome of Patients with Idiopathic Ventricular Fibrillation with or without the Brugada Syndrome , 1999, Journal of cardiovascular electrophysiology.
[65] P. Sutton,et al. Effect of Adrenergic Stimulation on Action Potential Duration Restitution in Humans , 2003, Circulation.
[66] Vincent Jacquemet,et al. Automaticity in acute ischemia: bifurcation analysis of a human ventricular model. , 2011, Physical review. E, Statistical, nonlinear, and soft matter physics.
[67] C. Tracy,et al. HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013. , 2013, Heart rhythm.
[68] N. Trayanova,et al. Action potential dynamics explain arrhythmic vulnerability in human heart failure: a clinical and modeling study implicating abnormal calcium handling. , 2008, Journal of the American College of Cardiology.
[69] S. Laniado,et al. Response of recurrent sustained ventricular tachycardia to verapamil. , 1981, British heart journal.
[70] Frank Bogun,et al. Relationship of frequent postinfarction premature ventricular complexes to the reentry circuit of scar-related ventricular tachycardia. , 2008, Heart rhythm.
[71] S. Pogwizd,et al. The contribution of nonreentrant mechanisms to malignant ventricular arrhythmias. , 1992, Basic research in cardiology.
[72] CIBIS-II Investigators and Committees. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial , 1999, The Lancet.
[73] Wouter-Jan Rappel,et al. Treatment of atrial fibrillation by the ablation of localized sources: CONFIRM (Conventional Ablation for Atrial Fibrillation With or Without Focal Impulse and Rotor Modulation) trial. , 2012, Journal of the American College of Cardiology.
[74] S. Narayan,et al. Long-term follow-up of idiopathic ventricular fibrillation ablation: a multicenter study. , 2009, Journal of the American College of Cardiology.
[75] A Garfinkel,et al. Electrophysiological heterogeneity and stability of reentry in simulated cardiac tissue. , 2001, American journal of physiology. Heart and circulatory physiology.
[76] Henggui Zhang,et al. The canine virtual ventricular wall: a platform for dissecting pharmacological effects on propagation and arrhythmogenesis. , 2008, Progress in biophysics and molecular biology.
[77] Natalia A Trayanova,et al. Mechanisms of Human Atrial Fibrillation Initiation: Clinical and Computational Studies of Repolarization Restitution and Activation Latency , 2012, Circulation. Arrhythmia and electrophysiology.
[78] Ruben Coronel,et al. Intrinsic heterogeneity in repolarization is increased in isolated failing rabbit cardiomyocytes during simulated ischemia. , 2003, Cardiovascular research.
[79] Robert F Gilmour,et al. Ionic mechanism of electrical alternans. , 2002, American journal of physiology. Heart and circulatory physiology.
[80] B Lown,et al. Monitoring for Serious Arrhythmias and High Risk of Sudden Death , 1975, Circulation.
[81] Hui-Nam Pak,et al. Catheter Ablation of Ventricular Fibrillation in Rabbit Ventricles Treated With &bgr;-Blockers , 2003 .
[82] D. Lin,et al. Catheter ablation of ventricular fibrillation: importance of left ventricular outflow tract and papillary muscle triggers. , 2014, Heart rhythm.
[83] A. L. Wit,et al. Spontaneous and Induced Cardiac Arrhythmias in Subendocardial Purkinje Fibers Surviving Extensive Myocardial Infarction in Dogs , 1973, Circulation research.
[84] Eric Fain,et al. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. , 2004, The New England journal of medicine.
[85] A. Castellanos,et al. Interpretation of outcomes of antiarrhythmic clinical trials: design features and population impact. , 1998, Circulation.
[86] A. Mahajan,et al. Cardiac sympathetic denervation in patients with refractory ventricular arrhythmias or electrical storm: intermediate and long-term follow-up. , 2014, Heart rhythm.
[87] Sanjiv M Narayan,et al. T-wave alternans, restitution of human action potential duration, and outcome. , 2007, Journal of the American College of Cardiology.
[88] Kumaraswamy Nanthakumar,et al. Ventricular fibrillation in myopathic human hearts: mechanistic insights from in vivo global endocardial and epicardial mapping. , 2007, American journal of physiology. Heart and circulatory physiology.
[89] F. Gaita,et al. Can spinal cord stimulation reduce ventricular arrhythmias? , 2012, Heart rhythm.
[90] W. Baxter,et al. Stationary and drifting spiral waves of excitation in isolated cardiac muscle , 1992, Nature.
[91] Wouter-Jan Rappel,et al. Theoretical considerations for mapping activation in human cardiac fibrillation. , 2013, Chaos.
[92] F. Ohsuzu,et al. Altered action potential dynamics in electrically remodeled canine atria: evidence for altered intracellular Ca2+ handling. , 2006, Circulation journal : official journal of the Japanese Circulation Society.
[93] Alan Garfinkel,et al. Action potential duration restitution and ventricular fibrillation due to rapid focal excitation. , 2002, American journal of physiology. Heart and circulatory physiology.
[94] Fach,et al. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF) , 1999, The Lancet.
[95] R. Ideker,et al. Activation becomes highly organized during long-duration ventricular fibrillation in canine hearts. , 2010, American journal of physiology. Heart and circulatory physiology.
[96] Po-Cheng Chang,et al. Epicardial ablation of rotors suppresses inducibility of acetylcholine-induced atrial fibrillation in left pulmonary vein-left atrium preparations in a beagle heart failure model. , 2011, Journal of the American College of Cardiology.
[97] A. Garfinkel,et al. Chaos and the transition to ventricular fibrillation: a new approach to antiarrhythmic drug evaluation. , 1999, Circulation.
[98] Karen L. Gunson,et al. Population-based analysis of sudden cardiac death with and without left ventricular systolic dysfunction: two-year findings from the Oregon Sudden Unexpected Death Study. , 2006, Journal of the American College of Cardiology.
[99] W. Rappel,et al. Modifying Ventricular Fibrillation by Targeted Rotor Substrate Ablation: Proof‐of‐Concept from Experimental Studies to Clinical VF , 2015, Journal of cardiovascular electrophysiology.
[100] David J. Christini,et al. Effect of β-adrenergic blockade on dynamic electrical restitution in vivo , 2004 .
[101] R. Ideker,et al. The effect of chemical ablation of the endocardium on ventricular fibrillation threshold. , 1986, Circulation.
[102] Hugh Calkins,et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. , 2004, The New England journal of medicine.
[103] M. Volpe,et al. Osteopontin and Galectin‐3 Predict the Risk of Ventricular Tachycardia and Fibrillation in Heart Failure Patients with Implantable Defibrillators , 2014, Journal of cardiovascular electrophysiology.
[104] A. Camm,et al. Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT , 1997, The Lancet.
[105] B. Wilkoff,et al. Differences in effects of electrical therapy type for ventricular arrhythmias on mortality in implantable cardioverter-defibrillator patients. , 2010, Heart rhythm.
[106] J. Ruskin,et al. Electrical alternans and vulnerability to ventricular arrhythmias. , 1994, The New England journal of medicine.
[107] J. Coote,et al. Autonomic modulation of electrical restitution, alternans and ventricular fibrillation initiation in the isolated heart. , 2007, Cardiovascular research.
[108] C Antzelevitch,et al. Cellular basis for the normal T wave and the electrocardiographic manifestations of the long-QT syndrome. , 1998, Circulation.
[109] Hani N. Sabbah,et al. Vagus nerve stimulation in experimental heart failure , 2011, Heart Failure Reviews.
[110] Douglas K Owens,et al. Cost-effectiveness of implantable cardioverter-defibrillators. , 2005, The New England journal of medicine.
[111] R. Berger,et al. Effects of statin therapy on arrhythmic events and survival in patients with nonischemic dilated cardiomyopathy. , 2006, Journal of the American College of Cardiology.
[112] H. Pak,et al. Both Purkinje cells and left ventricular posteroseptal reentry contribute to the maintenance of ventricular fibrillation in open-chest dogs and swine: effects of catheter ablation and the ventricular cut-and-sew operation. , 2008, Circulation journal : official journal of the Japanese Circulation Society.
[113] Vadim V Fedorov,et al. A novel low-energy electrotherapy that terminates ventricular tachycardia with lower energy than a biphasic shock when antitachycardia pacing fails. , 2012, Journal of the American College of Cardiology.
[114] Dan M. Roden,et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines , 2006 .
[115] Tachapong Ngarmukos,et al. Prevention of Ventricular Fibrillation Episodes in Brugada Syndrome by Catheter Ablation Over the Anterior Right Ventricular Outflow Tract Epicardium , 2011, Circulation.
[116] R. Clayton,et al. Whole heart action potential duration restitution properties in cardiac patients: a combined clinical and modelling study , 2006, Experimental physiology.
[117] A. Garfinkel,et al. From Pulsus to Pulseless: The Saga of Cardiac Alternans , 2006, Circulation research.
[118] M. Copass,et al. Changing incidence of out-of-hospital ventricular fibrillation, 1980-2000. , 2002, JAMA.
[119] Hui-Nam Pak,et al. Spatial Dispersion of Action Potential Duration Restitution Kinetics Is Associated with Induction of Ventricular Tachycardia/Fibrillation in Humans , 2004, Journal of cardiovascular electrophysiology.
[120] Arthur J Moss,et al. Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator. , 2013, European heart journal.
[121] A Garfinkel,et al. Role of papillary muscle in the generation and maintenance of reentry during ventricular tachycardia and fibrillation in isolated swine right ventricle. , 1999, Circulation.
[122] L. Tavazzi,et al. Early Protection Against Sudden Death by n-3 Polyunsaturated Fatty Acids After Myocardial Infarction Time-Course Analysis of the Results of the Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico (GISSI)-Prevenzione , 2002 .
[123] Mark A Hlatky,et al. ACC/AHA/HRS 2008 guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: executive summary. , 2008, Heart rhythm.
[124] Carl J. Wiggers,et al. Studies of Ventricular Fibrillation Caused by Electric Shock: , 1930, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.
[125] J. Weiss,et al. Suppression of re-entrant and multifocal ventricular fibrillation by the late sodium current blocker ranolazine. , 2011, Journal of the American College of Cardiology.
[126] Arthur L. Kellermann,et al. Predictors of Survival From Out-of-Hospital Cardiac Arrest A Systematic Review and Meta-Analysis , 2013 .
[127] S. Hohnloser,et al. Elevated Heart Rate Triggers Action Potential Alternans and Sudden Death. Translational Study of a Homozygous KCNH2 Mutation , 2014, PloS one.
[128] Maxime Sermesant,et al. Cardiac arrythmias: multimodal assessment integrating body surface ECG mapping into cardiac imaging. , 2014, Radiology.
[129] H L Greene,et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. , 1991, The New England journal of medicine.
[130] Wojciech Zareba,et al. Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: Proposed Modification of the Task Force Criteria , 2010, Circulation.